Jagan Valluri

Psychogenics (United States) — United States

Medicine · Health Sciences

10h-index343citations40works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(17), Cancer Cells and Metastasis(15), Cancer, Hypoxia, and Metabolism(11), Ovarian cancer diagnosis and treatment(7), Cancer Genomics and Diagnostics(7)

Publications40 total

ChemoID-guided therapy improves objective response rate in recurrent platinum-resistant ovarian cancer randomized clinical trial
npj Precision Oncology·2025· 2 citedOpen Access
Relationship of cancer stem cell functional assay and objective response rate of patients with recurrent platinum-resistant ovarian cancer in a randomized trial.
Journal of Clinical Oncology·2024
A New and Effective Procedure for Advanced Oral Cancer Therapy: The Potential of a Cancer Stem Cell Assay in Guiding Chemotherapy
Translational Medicine UniSa·2023· 4 citedOpen Access
Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial
Cell Reports Medicine·2023· 40 citedOpen Access
Treatment of unmethylated MGMT-promoter recurrent glioblastoma with cancer stem cell assay-guided chemotherapy and the impact on patients’ healthcare costs
Neuro-Oncology Advances·2023· 7 citedOpen Access
CTNI-17. A MULTI-INSTITUTIONAL RANDOMIZED CLINICAL TRIAL COMPARING ASSAY - GUIDED CHEMOTHERAPY WITH PHYSICIAN-CHOICE TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA (NCT03632135)
Neuro-Oncology·2022Open Access
SYST-01 MULTI-INSTITUTIONAL RANDOMIZED TRIAL COMPARING CANCER STEM CELL-TARGETED VS PHYSICIAN-CHOICE TREATMENTS IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS (NCT03632135)
Neuro-Oncology Advances·2022Open Access
Abstract CT224: Multi-institutional randomized phase-3 trial comparing cancer stem cell-targeted vs physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135)
Cancer Research·2022
Multi-institutional randomized phase 3 trial comparing cancer stem cell-targeted versus physician-choice treatments in patients with recurrent high-grade gliomas (NCT03632135).
Journal of Clinical Oncology·2022· 2 cited
Cancer stem cell assay for identification of effective treatments for platinum-resistant recurrent ovarian cancer.
Journal of Clinical Oncology·2022· 1 cited
STEM-21. CLINICAL RELEVANCE OF CANCER STEM CELL CYTOTOXICITY ASSAY IN GUIDING TREATMENT FOR GLIOBLASTOMA
Neuro-Oncology·2020Open Access
Clinical relevance of cancer stem cell chemotherapeutic assay for recurrent ovarian cancer
Translational Oncology·2020· 14 citedOpen Access
Expression of poly-ADP-ribose polymerase (PARP) in endometrial adenocarcinoma: Prognostic potential
Pathology - Research and Practice·2020· 2 citedOpen Access
Cancer Stem Cell Chemotherapeutics Assay for Prospective Treatment of Recurrent Glioblastoma and Progressive Anaplastic Glioma: A Single-Institution Case Series
Translational Oncology·2020· 27 citedOpen Access
STEM-13. CANCER STEM CELL CYTOTOXICITY ASSAY-GUIDED TREATMENT IN RECURRENT GLIOBLASTOMA AND PROGRESSIVE ANAPLASTIC GLIOMA
Neuro-Oncology·2019Open Access
Evaluation of cancer stem cell drug response assay in the treatment of recurrent ovarian cancer patients
Gynecologic Oncology·2019
Minimally Manipulative Method for the Expansion of Human Bone Marrow Mesenchymal Stem Cells to Treat Osseous Defects
International Journal of Molecular Sciences·2019· 10 citedOpen Access
STEM-01. PROSPECTIVE ANALYSIS OF CANCER STEM CELL DRUG RESPONSE ASSAY FOR GLIOBLASTOMA PATIENTS
Neuro-Oncology·2018Open Access
Effect of ghost pepper on cell proliferation, apoptosis, senescence and global proteomic profile in human renal adenocarcinoma cells
PLoS ONE·2018· 14 citedOpen Access
Prospective analysis of cancer stem cell drug response assay for glioblastoma patients.
Journal of Clinical Oncology·2018
page 1 of 2Next →

Frequent Co-authors

Pier Paolo Claudio(34), Candace M. Howard(22), Krista L. Denning(22), Anthony Alberico(14), Seth T. Lirette(13), Alexander Yu(11), Tulika Ranjan(7), Antonio Cortese(7), Logan Lawrence(7), Nadim Bou Zgheib(6), Soma Sengupta(5), Michael Glantz(5), Hugh D. Moulding(5), Jon Glass(5), Steven J. Jubelirer(5), Terrence Julien(5), Khaled Aziz(5), David H. Jho(5), Sarah E Mathis(5), Christine Lu‐Emerson(4)